Transgenic Expression of the Shortest Human Tau Affects Its Compartmentalization and Its Phosphorylation as in the Pretangle Stage of Alzheimer's Disease
- 31 January 1999
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 154 (1), 255-270
- https://doi.org/10.1016/s0002-9440(10)65272-8
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filamentsFEBS Letters, 1996
- Neurodegenerative disorders with extensive tau pathology: A comparative study and reviewAnnals of Neurology, 1996
- Characterization of mAb AP422, a novel phosphorylation‐dependent monoclonal antibody against tau proteinFEBS Letters, 1996
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995
- Sorting mechanisms of Tau and MAP2 in neurons: Suppressed axonal transit of MAP2 and locally regulated microtubule bindingNeuron, 1995
- Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule bindingNeuron, 1993
- Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinaseNeuroscience Letters, 1992
- A distinct form of tau is selectively incorporated into Alzheimer's paired helical filamentsBiochemical and Biophysical Research Communications, 1989
- Microtubule-associated proteins and in vitro astrocyte differentiation.The Journal of cell biology, 1985